+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rotarix"

From
Rotavirus Vaccine Market Report 2025 - Product Thumbnail Image

Rotavirus Vaccine Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Rotavirus Prophylaxis Market Report 2025 - Product Thumbnail Image

Rotavirus Prophylaxis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Rotavirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 277 Pages
  • Global
From
From
Europe Vaccines Market Outlook, 2028 - Product Thumbnail Image

Europe Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 112 Pages
  • Europe
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Rotarix is a vaccine used to protect against rotavirus, a virus that causes severe diarrhea in infants and young children. It is a live, oral vaccine that is administered in two doses, typically given at two and four months of age. The vaccine is approved for use in over 100 countries and is recommended by the World Health Organization (WHO) as part of the routine immunization schedule for infants. Rotarix is a part of the larger global vaccine market, which includes a variety of products used to protect against a range of infectious diseases. Vaccines are an important tool in public health, helping to reduce the spread of disease and protect vulnerable populations. The Rotarix market is dominated by a few large pharmaceutical companies, including GlaxoSmithKline, Merck, and Sanofi Pasteur. Other companies, such as CSL and Pfizer, also produce rotavirus vaccines. Show Less Read more